◆ A113 Patent Commercialization Intelligence
Your patents versus the federal budget.
A113 runs issued patent portfolios against the published federal R&D demand signal — the Department of War budget, NIH, NSF, DOE, NASA, and the SBIR/STTR pipeline — and returns a ranked, evidence-linked map of where each invention intersects funded government work. Universities, companies, research foundations, national laboratories, and independent inventors. If you hold issued U.S. patents, the analysis applies.
The Gap
The federal government tells you exactly what it will fund. Almost nobody reads it.
Every year the federal government publishes tens of thousands of pages describing what it intends to fund: program element justifications, budget line items, congressional adds and marks, solicitation topics, grant program announcements, and agency modernization priorities. Taken together they represent more than $200 billion in annual federal research and development demand, stated in the government's own words, in public.
Patent holders almost never read this material at portfolio scale. The reason is arithmetic, not indifference. Matching a thousand-patent portfolio against tens of thousands of federal program lines is tens of millions of comparisons — work that has never been economically feasible for a licensing office, a corporate IP group, or an individual inventor. So the connection between issued invention and funded federal demand gets made by accident, by relationship, or not at all.
That arithmetic has changed. The gap was never technical or legal. It was connective, and it was a compute problem.
What We Do
A patent-to-program match engine, run across the federal demand signal.
Portfolio Scoring Against Federal Demand
Every patent in the portfolio is scored against the active federal R&D demand corpus — program elements and budget justification text, congressional adds, solicitation topics, and grant program announcements across the Department of War, NIH, NSF, DOE, NASA, and SBIR/STTR. Output distinguishes strong-fit matches from directional alignment, and says plainly which patents sit outside funded demand today.
Named Licensee, Partner, and Acquirer Identification
For each high-alignment patent, the engine identifies specific organizations — primes, small businesses, dual-use commercial firms, and current federal performers — whose contract history, technology positions, and existing patent holdings make them qualified counterparties. The output is a ranked, named list, not a market category.
Program Office and Sponsor Mapping
Identifies the program offices, program managers, and funding mechanisms behind each aligned line, and surfaces the congressional committee and district relationships that intersect the technology area. Translates a patent portfolio into the federal customer landscape that actually funds commercialization.
Commercialization Pathway Analysis
Each high-priority patent receives a recommended pathway: license to an established prime, partner with an SBIR/STTR performer, pursue a dual-use commercial route, or position for strategic acquisition. Each pathway names the candidate counterparties and the federal funding mechanism that supports the transition.
Method
No invented numbers. Ever.
Commercialization reports in this market are frequently padded with fabricated precision — invented market sizes, assigned readiness levels, made-up probability scores. We do not produce any of it. Every figure in an A113 report traces to a published federal budget document, an issued patent record, or a federal award. Every claim carries a confidence marker:
VERIFIED
drawn directly from a published federal or USPTO source, with the source cited.
INFERRED
a reasoned conclusion from verified inputs, with the reasoning shown.
DIRECTIONAL
a judgment call, labeled as one.
An absent section is better than a confabulated one. Where the data does not support a finding, the report says so. Reports read like a research institution's assessment, because that is what they are.
Process
Four steps, starting with a free briefing.
Free highlight briefing
We run your portfolio through the engine and deliver a no-cost highlight briefing: the headline alignment findings, the count of strong-fit matches, the federal programs and agencies involved, and a sample of the evidence behind them. No commitment, no data required from you beyond the identity of the portfolio. It is the fastest way to know whether the full analysis is worth commissioning.
Scope the engagement
Together we set the boundary: the full portfolio, a single research center or business unit, a technology area, or a discrete set of patents already under active commercialization. Scoring weights are tuned to your priorities — you decide whether near-term licensing revenue, program-of-record positioning, or long-horizon strategic alignment drives the ranking.
Run the full analysis
The engine executes the complete match across the federal demand corpus, resolves counterparties, maps program offices and sponsors, and assembles the evidence chain for each finding. Where you hold proprietary context — active negotiations, inventor input, prior licensing history — it is fed back into the model and reflected in the output.
Deliver, brief, and refresh
You receive a structured analysis document and a working session with your team. Federal budgets change every year; so does the answer. Annual refresh produces a delta report showing what moved — new alignments, programs that gained or lost funding, and counterparties whose positions shifted.
Who This Is For
If you hold issued U.S. patents, the analysis applies.
◆ Universities and Research Foundations
Technology licensing offices, applied research laboratories, and university-affiliated research centers. This is where the product was built and proven.
See the university track◆ Companies with Issued IP
Operating companies whose patent estates contain more federal relevance than their business development teams have bandwidth to pursue — including IP acquired in a transaction and never systematically evaluated.
◆ National Laboratories and FFRDCs
Institutions with large federally-derived portfolios and a statutory technology transfer mandate.
◆ Independent Inventors and IP Holders
Individual inventors, small portfolios, and IP holding entities. The engine does not care about portfolio size. A single patent either intersects funded federal demand or it does not.
Engagements
Two engagement structures.
Portfolio Analysis
A one-time comprehensive analysis of the portfolio against current federal demand.
- Full portfolio scoring against whole-of-government R&D demand
- Strong-fit matches identified and ranked with evidence links
- Named licensee, partner, and acquirer candidates for each
- Program office and congressional sponsor mapping
- Commercialization pathway recommendations
- Customizable scoring weights
- Working session with your team
Delivery
Scoped per engagement
Annual Intelligence Subscription
A live relationship that keeps the analysis current as budgets move.
- Everything in Portfolio Analysis
- Annual refresh with delta reporting — what changed and why
- New-patent scoring as the portfolio grows
- Quarterly review sessions
- Congressional mark-up analysis affecting your technology areas
- Named-counterparty introduction support
Delivery
12-month minimum engagement
Pricing is scoped to portfolio size, agency coverage, and engagement depth. The highlight briefing is free. University and research-institution portfolio engagements typically fall between $60,000 and $150,000 annually. Company, laboratory, and individual-inventor portfolios are scoped to the same basis. Contact us for a scoping conversation.
About A113
Operators at the intersection of research, capital, and federal markets.
A113 Partners is an engineering and intelligence firm based in Dallas with operations in Washington and New York. The principal has founded and exited advanced technology companies — most recently a leader in two-phase liquid immersion cooling acquired by a Fortune 1000 industrial — and holds 25+ patents across robotics, post-quantum security, advanced batteries, and edge infrastructure. Our platform is built and operated by people who have done the commercialization work, not consulted on it from the outside.
FAQ
Common questions from patent holders.
Find out what your portfolio is worth to the federal government.
The highlight briefing is free and the scoping conversation is thirty minutes. If your patents intersect funded federal demand, you will know quickly. If they do not, you will know that too.